|1.||Nash, Craig A: 1 article (08/2015)|
|2.||Challiss, R A John: 1 article (08/2015)|
|3.||Willets, Jonathon M: 1 article (08/2015)|
|4.||Rainbow, Richard D: 1 article (08/2015)|
|5.||Nelson, Carl P: 1 article (08/2015)|
|6.||Michal, Allison M: 1 article (12/2011)|
|7.||Tran, Thai H: 1 article (12/2011)|
|8.||Benovic, Jeffrey L: 1 article (12/2011)|
|9.||Liu, Chengbao: 1 article (12/2011)|
|10.||Rui, Hallgeir: 1 article (12/2011)|
|1.||Breast Neoplasms (Breast Cancer)
12/01/2011 - "Overall, these studies demonstrate that arrestin2 levels decrease while arrestin3 levels increase during breast cancer progression and these changes correlate with a poor clinical outcome."
12/01/2011 - "Arrestin3 was also an independent prognostic marker of breast cancer with a hazard ratio of 1.65. "
12/01/2011 - "In contrast, arrestin3 expression significantly increased during breast cancer progression (P < 0.001) and increased expression was associated with decreased survival (P = 0.014). "
12/01/2011 - "Examination of the expression of the two nonvisual arrestins, arrestin2 and 3, in various breast cancer cell lines revealed comparable expression of arrestin3 in basal and luminal lines while arrestin2 expression was much higher in the luminal lines compared to the more aggressive basal lines. "
|2.||Retinoblastoma (Glioblastoma, Retinal)
09/15/2004 - "Expression of X-arrestin was detected at a low level in the Y79 retinoblastoma cell line but not in the WERI retinoblastoma cell line. "
09/15/2004 - "In order to delineate the promoter structure necessary for the pan-cone-specific expression of X-arrestin, the expression of the gene in retinoblastoma cell lines was investigated, and a structure-function analysis of the promoter was conducted in the appropriate cellular substrate. "
|4.||Hypertension (High Blood Pressure)
|3.||enhanced green fluorescent protein